CT Lung Nodule Assessment (LNA)

For diagnostic use and low-dose CT lung cancer screening

An advanced imaging package for the segmentation, quantification and follow-up of physician-indicated lung nodules, that can be used in both diagnostic and screening evaluations, supporting Low Dose CT Lung Cancer Screening.*

lung nodule assessment thumbnail

Benefits

  • One-click volume segmentation with advanced reporting tools to allow efficiently export results in various formats while supporting LungRADS categorization.
  • Workflow and decision support tools streamline follow-up readings, together with a Risk Calculator tool based on patient and nodule characteristics for estimation of the probability that lung nodules detected on baseline screening low-dose CT scans are malignant.
  • 2017 Fleischner criteria for incidental findings.
  • Features pre-filled data including characteristics for each nodule in configurable presets.

*The screening must be performed within the established inclusion criteria of programs/protocols that have been approved and published by either a governmental body or professional medical society. Please refer to clinical literature, including the results of the National Lung Screening Trial (N Engl J Med 2011; 365:395-409) and subsequent literature, for further information. Some functionalities may not be available in all territories. Please contact Philips representative for more details.

Vores websted vises bedst med den nyeste version af Microsoft Edge, Google Chrome eller Firefox.